Search

everythinglearnresearchcommunity

for

Search:↓

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

Dermatophycosis is a treatable fungal skin infection spread by contact with infected animals.

An 8-year-old boy with hair-pulling disorder had a bald patch that was confirmed not to be a fungal infection and was treated with therapy.

The nanofibers with two growth factors improved wound healing by supporting structure, preventing infection, and aiding tissue growth.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Skin and nail problems like hair loss, dry skin, and fungal infections are common in people with long-term Type 2 Diabetes and can be prevented with good blood sugar control and foot care.

Doctors don't use trichoscopy enough, even though it's good for diagnosing hair problems.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Finasteride may help prevent chronic bacterial prostatitis, with better results when combined with antibiotics.

The treatment might help COVID-19 related hair loss, but more research is needed.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Coconut seed extract may effectively treat scabies in rabbits by killing mites and reducing inflammation.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

The new device safely and effectively rejuvenates skin, making it thicker and healthier.